Llwytho...
Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome
A 30-year-old Caucasian man presented with severe Cushing's syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor. The patient remained hypercortisolemic despite treatment with steroidogenesis inhibitors, chemotherapy, and octr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Case Rep Endocrinol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Hindawi Publishing Corporation
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4773543/ https://ncbi.nlm.nih.gov/pubmed/26989527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/8453801 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|